Treatment of Latent Tuberculosis in Socially Marginalised Citizens
Status:
Recruiting
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
An open-label, randomised controlled trial comparing compliance to treatment for latent
tuberculosis infection in socially marginalised citizens. Participants will be randomized to
either daily isoniazid for 6 months or weekly rifapentine and isoniazid as directly observed
therapy for twelve weeks.